Application of the 2013 American College of Cardiology/American Heart Association Cholesterol Guideline to the Korean National Health and Nutrition Examination Surveys from 1998 to 2012

다국어 초록 (Multilingual Abstract)

Background: The 2013 American College of Cardiology/American Heart Association (ACC/AHA) guideline for the treatment of blood cholesterol recommends statin therapy for individuals at high risk of atherosclerotic cardiovascular disease (ASCVD). The aim of this study was to investigate serial trends in the percentages of Korean adults considered eligible for statin therapy according to the new ACC/AHA cholesterol guideline.
Methods: Data from the Korean National Health and Nutrition Examination Survey (KNHANES) I (1998, n=7,698), II (2001, n=5,654), III (2005, n=5,269), IV (2007 to 2009, n=15,727), and V (2010 to 2012, n=16,304), which used a stratified, multistage, probability sampling design, were used as representative of the entire Korean population.
Results: The percentage of adults eligible for statin therapy according to the ACC/AHA cholesterol guideline increased with time: 17.0%, 19.0%, 20.8%, 20.2%, and 22.0% in KNHANES I, II, III, IV, and V, respectively (P=0.022). The prevalence of ASCVD was 1.4% in KNHANES I and increased to 3.3% in KNHANES V. The percentage of diabetic patients aged 40 to 75 years with a low density lipoprotein cholesterol levels of 70 to 189 mg/dL increased from 4.8% in KNHANES I to 6.1% in KNHANES V. People with an estimated 10-year ASCVD risk ≥7.5% and aged 40 to 75 years accounted for the largest percentage among the four statin benefit groups: 9.1% in KNHANES I and 11.0% in KNHANES V.
Conclusion: Application of the 2013 ACC/AHA guideline has found that the percentage of Korean adults in the statin benefit groups has increased over the past 15 years.

참고문헌 (Reference)

1 "World Health Organization: World health statistics 2015"

2 Chia YC, "Validation of the pooled cohort risk score in an Asian population: a retrospective cohort study" 14 : 163-, 2014

3 하경화, "Trends in the Diabetes Epidemic in Korea" 대한내분비학회 30 (30): 142-146, 2015

4 Kantor ED, "Trends in prescription drug use among adults in the United States from 1999-2012" 314 : 1818-1831, 2015

5 Moran AE, "The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study" 129 : 1493-1501, 2014

6 Li YF, "The difference between Asian and Western in the effect of LDL-C lowering therapy on coronary atherosclerotic plaque: a metaanalysis report" 15 : 6-, 2015

7 MPH for the Cardiovascular Health Study Research Group (CHS), "The Cardiovascular Health Study: design and rationale" 1 : 263-276, 1991

8 The ARIC investigators, "The Atherosclerosis Risk in Communities (ARIC) study: design and objectives" 129 : 687-702, 1989

9 "Statistics Korea: Annual report on the causes of death statistics 2014"

10 Lee YH, "Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: nationwide surveys (KNHANES 2008-2011)" 63 : 776-786, 2016

11 Huang ES, "Projecting the future diabetes population size and related costs for the U.S" 32 : 2225-2229, 2009

12 Nakamura H, "Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial" 368 : 1155-1163, 2006

13 노은, "Prevalence and Management of Dyslipidemia in Korea:Korea National Health and Nutrition Examination Survey during 1998 to 2010" 대한당뇨병학회 37 (37): 433-449, 2013

14 "OECD: Pensions at a glance 2015: OECD and G20 indicators" OECD Publishing

15 Ford I, "Long-term follow-up of the West of Scotland Coronary Prevention Study" 357 : 1477-1486, 2007

16 Lloyd SM, "Long-term effects of statin treatment in elderly people: extended follow-up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)" 8 : e72642-, 2013

17 Kasai T, "Long-term (11-year) statin therapy following percutaneous coronary intervention improves clinical outcome and is not associated with increased malignancy" 114 : 210-217, 2007

18 Korean Diabetes Association, "Korean diabetes fact sheet in Korea 2015"

19 JBS3 Board, "Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3)" 100 (100): ii1-ii67, 2014

20 Kim KM, "Interactions between dietary calcium intake and bone mineral density or bone geometry in a low calcium intake population (KNHANES IV 2008-2010)" 99 : 2409-2417, 2014

21 "Institute for Health Metrics and Evaluation (IHME): Global burden of disease study 2013 (GBD 2013)"

22 Lim S, "Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998-2007" 34 : 1323-1328, 2011

23 Warnick GR, "Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints" 36 : 15-19, 1990

24 Heart Protection Study Collaborative Group, "Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 highrisk individuals: a randomised controlled trial" 378 : 2013-2020, 2011

25 Nohara R, "Effect of long-term intensive lipidlowering therapy with rosuvastatin on progression of carotid intima-media thickness: Justification for Atherosclerosis Regression Treatment (JART) extension study" 77 : 1526-1533, 2013

26 Kweon S, "Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES)" 43 : 69-77, 2014

27 Ueshima H, "Cardiovascular disease and risk factors in Asia: a selected review" 118 : 2702-2709, 2008

28 Friedman GD, "CARDIA: study design, recruitment, and some characteristics of the examined subjects" 41 : 1105-1116, 1988

29 Kannel WB, "An investigation of coronary heart disease in families. The Framingham offspring study" 110 : 281-290, 1979

30 Dawber TR, "An approach to longitudinal studies in a community: the Framingham Study" 107 : 539-556, 1963

31 Stone NJ, "2013ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines" 63 (63): 2889-2934, 2014